Announcements Trials
Browse Landscape

Phase

Phase 3 8Phase 4 3Phase 1 3Phase 2 2Phase 1/2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 12INDUSTRY 3NIH 2

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Papillomavirus Infections 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Herpes Zoster 1Condylomata Acuminata 1Anus Neoplasms 1

Interventions

pembrolizumab 304Paclitaxel 206Carboplatin 200Gemcitabine 173Cisplatin 139Docetaxel 138Cyclophosphamide 136Nivolumab 129Bevacizumab 118Injections 111fludarabine 96atezolizumab 91Pemetrexed 90Dexamethasone 90Cetuximab 90Fluorouracil 84Irinotecan 77Rituximab 72Capecitabine 72venetoclax 71Azacitidine 70130-nm albumin-bound paclitaxel 67Leucovorin 65Fulvestrant 58Oxaliplatin 57durvalumab 56Trastuzumab 56Lenalidomide 55Ipilimumab 55Midazolam 54

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × INDUSTRY × Vaccines × Clear all
NCT05680454 2023-01-17

A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine

Beijing Health Guard Biotechnology, Inc

Phase 1 Completed
160 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

NCT05672966 2023-01-06

Phase I Clinical Trial of a Candidate HPV Vaccine

Wuhan BravoVax Co., Ltd.

Phase 1 Unknown
40 enrolled

Papillomavirus Infections

NCT01460719 2019-03-11

V212-013

Merck Sharp & Dohme LLC

Phase 1 Completed
80 enrolled 13 charts

Herpes Zoster

Data powered by HemOnc (CC BY 4.0) Colophon âš¡